COVID-19 test kit iFlash

for antigensSARS-COV-2coronavirus

Reliable Result: High Sensitivity and Specificity High Throughput: Up to 300 T/h Full Automation: Automated workflow reduces manual operation and avoids cross-infection to make the operators safety. Reputation: iFlash CLIA solutions have been applied and evaluated by more than one hundred of published academic studies. WHO Suggested Application Scenarios: 1. To identify suspected outbreaks of COVID-19 in regions where nucleic acid amplification tests (NAATs) is not immediately available 2. To screen at risk individuals and prioritize positive sample for further NAAT confirmation during outbreak 3. Early detection and isolation of positive cases in health facilities, testing centers, airport, customs, prisons, schools, front-line and health-care workers 4. To test asymptomatic contacts of positive cases Clinical Benefits: 1. Detect the presence of SARS-CoV-2 nucleocapsid protein 2. Identify the most infectious status of a COVID-19 positive person within the first seven days of symptom onset 3. Solely used as a supplementary test indicator in: - Suspected cases with negative nucleic acid test result - Conjunction with nucleic acid test in the diagnosis of suspected cases 4. When compared with NAAT: -- Shorter turnaround time -- Easy operation, fully automation -- Easy access to laboratories from small to big -- Reliable aid for rapid screening.